Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. (Q54102500)

24 May 2018

title

Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. (English)

1 reference

24 May 2018

author name string

Atz AM

1

1 reference

24 May 2018

Adatia I

2

1 reference

24 May 2018

Lock JE

3

1 reference

24 May 2018

Wessel DL

4

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

24 May 2018

Journal of the American College of Cardiology

published in

1 reference

24 May 2018

volume

33

1 reference

24 May 2018

issue

3

1 reference

24 May 2018

page(s)

813-819

1 reference

24 May 2018

Pulmonary vascular disease with congenital heart lesions: pathologic features and causes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Effect of breathing oxygen on pulmonary artery pressure and pulmonary vascular resistance in patients with ventricular septal defect.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Pulmonary vascular resistance in complete atrioventricular septal defect. A comparison between children with and without Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Modification of pulmonary hypertension secondary to congenital heart disease by prostacyclin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Inhaled nitric oxide in congenital heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Effects of oxygen and nitric oxide in oxygen on pulmonary arterial pressures of children with congenital cardiac defects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Hemodynamic effects of supplemental oxygen administration in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

Hemodynamic effects of inhaled nitric oxide in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900668-8

7 January 2021

10.1016/S0735-1097(98)00668-8

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10080486

1 reference

24 May 2018